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Abstract The expression of the cellular protooncogene c-ski
was examined in the rat uterus. In situ hybridization revealed
that c-ski mRNA was expressed in the uterus of the adult rat on
the day of estrous and localized mainly in the luminal and
glandular epithelia. To test the possibility that the expression of
c-ski mRNA is induced by estrogen, rats were ovariectomized
and estradiol-17L (E2) was injected. The expression of c-ski
mRNA was upregulated 3 h after E2 treatment, reaching the
highest level at 6 h and this persisted until 24 h; the E2-induced
expression of c-ski mRNA was restricted to the luminal and
glandular epithelia. These results suggest that the c-ski gene
plays a role in uterine epithelial cell proliferation and mediates
the proliferative action of E2.
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1. Introduction
C-ski is a cellular protooncogene, which was originally
shown to induce myogenesis when transfected to non-myo-
genic quail embryo cells in vitro [1]. Transgenic mice express-
ing the c-ski gene under the control of a murine sarcoma virus
long terminal repeat showed large increases in their skeletal
muscle mass [2], while c-ski de¢cient mice have defects in their
skeletal muscle development [3]. These results suggested that
the c-ski gene product (Ski) is involved in both the prolifer-
ation and di¡erentiation of skeletal muscle cells during devel-
opment [2,3]. However, little is known about the pathways
through which Ski expresses its disparate activities.
The uterus comprises several cell types including epithelial,
stromal and myometrial cells. Of these cells, the luminal and
glandular epithelial cells proliferate in response to estrogen
treatment in the rodent [4]. The presence of estrogen receptors
in the uterine epithelial cells has been shown and a number of
regulatory factors that mediate uterine responses to estrogen
have been identi¢ed. Among these factors are nuclear proto-
oncogenes such as c-fos and c-jun [5]. Transient expression of
these protooncogenes is rapidly induced by estrogen preceding
the initiation of proliferation of uterine epithelial cells [5^7].
Recently, it was shown that Ski exerts its e¡ect by modulating
retinoic acid receptor signaling [8] and it was suggested that
some of the biological activities of nuclear hormone receptors
are in part modulated by Ski [8]. Considering the interaction
between Ski and nuclear receptors, it would be of value to
examine if the c-ski gene is expressed in uterine epithelial cells
and if so, these cells would be a good model to test the pos-
sibility that Ski mediates the proliferative e¡ect of estrogen in
these cells. In fact, the c-ski gene is known to be expressed in
the uterus of adult mouse though its cellular localization is
unknown [9]. The present study, therefore, was conducted to
determine the cellular localization of the c-ski gene in the
uterus of the rat and to examine whether the uterine expres-
sion of the c-ski gene is regulated by estrogen.
2. Materials and methods
2.1. Animals and tissues
Adult cycling female Wistar Imamichi rats were purchased from the
Imamichi Institute of Animal Reproduction (Ibaraki, Japan). Rats
were housed under controlled light (14 h light:10 h dark) and food
and water were given ad libitum. They were ovariectomized (OVX)
under light ether anesthesia and estradiol-17L (E2, Sigma, St. Louis,
MO, USA) dissolved in 0.2 ml of sesame oil was injected subcutane-
ously after 1 week or later. At 0 (before injection of E2), 1, 3, 6, 12 or
24 h after E2 treatment, rats were killed by cervical dislocation and
uterine tissues were collected and snap frozen in liquid nitrogen or
embedded in OCT compound (Sakura Finetechnical, Tokyo, Japan).
The obtained samples were stored at 380‡C until use.
2.2. Reverse transcription-polymerase chain reaction (RT-PCR)
Cellular RNA was extracted from each tissue using TRIzol reagent
(Gibco BRL, New York). One microgram of the cellular RNA was
reverse-transcribed into its cDNA using SuperScript II (Gibco BRL,
New York) in a reaction volume of 20 Wl according to the manufac-
turer’s protocol. The reaction mixture contained 60 mM Tris-HCl (pH
8.5), 15 mM (NH4)2SO4, 2 mM MgCl2, 0.5 mM each of dATP, dTTP,
dGTP and dCTP, 5 mM random hexamer and 200 U SuperScript II.
Two microliters out of 20 Wl was used as a template for further PCR.
The primer set used for ampli¢cation of the partial rat c-ski cDNA
fragment consists of the forward primer, 5P-ACC ATC TCG TGC
TTC GTG GTG GGA-3P and the reverse primer, 5P-CTC CTT GCC
CGT GTA ATC CTG GCT-3P, and was designed on the basis of the
DNA sequences of the mouse [10] and human [11] c-ski gene pub-
lished in the literature [12]. The predicted PCR ampli¢ed sequence
was set within exon 1 of the c-ski gene because of its high homology
with the mouse [10] and human [11] c-ski, and a 561 bp product was
expected to be generated [12]. Fifty microliters of the reaction mixture
contained 2 Wl of reverse transcription reaction as above, 60 mM Tris-
HCl (pH 8.5), 15 mM (NH4)2SO4, 2 mM MgCl2, 200 WM each of
dATP, dTTP, dGTP and dCTP, 10 pmol of each primer, and 1.25 U
Taq polymerase (rTaq polymerase, Takara, Japan). PCR ampli¢ca-
tion was performed in a Perkin Elmer DNA thermal cycler model 480,
under the following conditions: 1 cycle of 94‡C for 5 min; 30 cycles of
94‡C for 1 min, 55‡C for 1 min, 72‡C for 1 min; 1 cycle of 72‡C for 10
min. After PCR, an aliquot of the reaction mixture was electropho-
resed on 1% TAE agarose gel and the products were stained with
ethidium bromide. The DNA sequence of the PCR product was de-
termined and was judged to be a partial fragment of the rat c-ski
cDNA since it showed high similarity (s 93%) to that of the corre-
sponding region of the mouse [10] and human [11] counterparts. The
number of cycles used for PCR was chosen so that the amount of
RNA used for RT-PCR versus the intensity of the ethidium bromide-
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stained product on agarose gel was within a linear range. The equality
of the amount of cDNA samples used for PCR of rat c-ski was
veri¢ed by PCR using the primer set of rat G3PDH (Clontech, CA,
USA). Quantitative analysis of the expression of c-ski mRNA was
performed on the photo of the gel using NIH image software (NIH,
ver. 1.62) and the data are expressed as ‘pixel’.
2.3. In situ hybridization
The PCR product of rat c-ski cDNA (561 bp) was subcloned into a
plasmid vector pGEM-T (Promega, Madison, WI, USA). The plasmid
was linearized by an appropriate restriction enzyme and digoxigenin
(DIG)-UTP labeled cRNA probes were synthesized using T7/SP6
RNA polymerase (DIG RNA labeling kit, Boehringer Mannheim,
Germany).
Cryostat sections (5 Wm thick) of the rat uterine tissues from 0 to 24
h were mounted on slides coated with 2.3% Vectabond reagent (Vec-
tor Laboratory, CA, USA) in acetone. The sections were ¢xed with
3% paraformaldehyde (PFA) in phosphate bu¡ered saline (PBS) for
60 min at room temperature, washed for 10 min in PBS and then
processed according to the method of Hirota et al. [13]. DIG-labeled
cRNA in the tissue sections was detected after overnight incubation
with an anti-DIG alkaline phosphatase-conjugated antibody (Nucleic
Acid Detection Kit, Boehringer Mannheim, Germany) at a dilution of
1:500. The slides were mounted in glycerol gel and examined under
bright-¢eld microscopy.
2.4. Immunohistochemistry
Frozen tissue sections (5 Wm thick) prepared from the rat uterine
tissues (0, 6 and 24 h after E2 treatment) were subjected to immuno-
histochemical analysis for the detection of proliferating cell nuclear
antigen (PCNA). All procedures were performed at room tempera-
ture. The sections were ¢xed in 3% PFA in PBS for 30 min, followed
by incubation in 0.1% Triton X-100 in PBS for 15 min. After washing
in PBS, endogenous peroxidase activity was inactivated by incubation
in 0.3% hydrogen peroxide in methanol for 30 min. Then the sections
were immersed in blocking solution (8% skim milk in PBS) for 30
min. The primary antibody speci¢c for PCNA (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) (dilution 1:100 with 1% BSA in PBS)
was applied and incubated for 90 min. As a secondary antibody,
biotin-labeled goat anti-mouse IgG (Kirkegaard and Perry Labora-
tory, MD, USA; diluted at 1:100 with 1% BSA in PBS) was used and
incubation was performed for 40 min. Detection of the signal for
PCNA was performed using the avidin-biotin complex system (Vec-
tastain ABC kit, Vector Laboratory, CA, USA). The speci¢city of the
primary antibody used for the presence of PCNA has been con¢rmed
using tissue sections from rat small intestine (see Fig. 4D).
2.5. Statistical analysis
The graphed data were analyzed by ANOVA followed by t-test.
Di¡erences were considered signi¢cant at P6 0.05.
3. Results
3.1. The c-ski gene is expressed in the uterine luminal and
glandular epithelial cells of the rat on the day of estrous
In situ hybridization was performed to determine the local-
ization of c-ski mRNA in the uterine tissue sections of the rat
obtained on the day of estrous. The DIG-labeled antisense c-
ski cRNA probe was detected in the luminal and glandular
Fig. 1. In situ hybridization analysis on the expression of c-ski mRNA in the uterine tissues from adult female rats on the day of estrous. A
and B: Antisense cRNA probe speci¢c to rat c-ski was used. C: Sense probe (control). GE, glandular epithelium; LE, luminal epithelium.
Magni¢cation, U220 (A and C), U870 (B).
Fig. 2. Quantitative RT-PCR analysis of the temporal expression of
c-ski mRNA in the uterus of OVX+E2-treated rats. A: Representa-
tive photograph of ethidium bromide-stained gel. The PCR product
of c-ski is indicated by an arrow. Numbers above the photograph
show time (hours) after E2 treatment. B: Changes in the expression
of c-ski mRNA. Data are expressed as the mean þ S.E.M. Four to
six samples were used at each time point, and similar results were
obtained in several independent experiments. #P6 0.05, ##P6 0.01
vs. 0 h.
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epithelial cells (Fig. 1A,B), while no signal was found when
sense cRNA probe was used (Fig. 1C).
3.2. Administration of E2 induces the expression of the c-ski
gene in the uterus of OVX rats
To examine the e¡ect of E2 on the expression of c-ski
mRNA in the rat uterus, OVX rats were treated with 1 Wg
of E2 (s.c.) and the uterine tissues were collected. The relative
expression level of c-ski mRNA at each time point was com-
pared using quantitative RT-PCR analysis. The administra-
tion of E2 caused a signi¢cant (P6 0.05) increase at 3 h,
which maximized at 6 h and this level was maintained at 24
h (Fig. 2).
3.3. E2 induces the c-ski gene speci¢cally in the uterine luminal
and glandular epithelium of OVX rats
The result of quantitative RT-PCR analysis revealed that
expression of c-ski mRNA is induced by E2 treatment in OVX
rats. To determine the cellular localization of c-ski mRNA
expression induced in this manner, in situ hybridization was
performed. At 0 and 1 h, only a faint staining showing the
presence of c-ski mRNA was detected in the subepithelial
stromal and glandular epithelial cells (Fig. 3A,B). In the lu-
minal epithelial cells, a signi¢cant message was ¢rst detected
at 3 h and thereafter strong expression persisted both in the
luminal and in the glandular epithelial cells up to 24 h (Fig.
3C^F). The relative cellular expression patterns during 0^24 h
are summarized in Table 1.
3.4. Proliferation of uterine epithelial cells is induced by E2
treatment in OVX rats
Administration of E2 to OVX rats is known to induce pro-
liferation of uterine epithelial cells [7]. To con¢rm that this is
the case in our study, immunohistochemical analysis of the
expression of PCNA, a marker of proliferating cells, was per-
formed. Immunohistochemical analysis of the expression of
PCNA in the uterine tissues revealed that no positive staining
was observed at 0 and 6 h (Fig. 4A,B), while speci¢c staining
was present in the luminal and glandular epithelial cells at 24
h (Fig. 4C). The speci¢city of the antibody used in the present
work was veri¢ed by the application of this method on a
tissue section from rat small intestine that resulted in positive
staining in the actively dividing epithelial cells (Fig. 4D).
4. Discussion
The cellular protooncogene c-ski was originally found as a
transcriptional regulatory factor which could induce di¡eren-
tiation of non-skeletal muscle cells to a skeletal muscle lineage
[1], and most studies on the function of the c-ski gene have
focused on its role in myogenesis (for review, see [14]). In
addition to skeletal muscle, the expression of this gene is dis-
tributed to a variety of tissues and this was true in the repro-
ductive tissues such as uterus, ovary and so on [9] though no
study on the expression and role of this gene has been per-
formed in these tissues. In this regard, the present study dem-
onstrated for the ¢rst time the localization of c-ski message in
the uterine tissues and that its expression is under the in£u-
ence of E2.
In our in situ hybridization analysis, the expression of c-ski
message in both the glandular and luminal epithelium was
¢rst up-regulated 3^6 h after E2 treatment. On the other
hand, the result obtained by quantitative RT-PCR analysis
also revealed that the c-ski message in the uterus signi¢cantly
Fig. 3. In situ hybridization analysis to locate the expression of c-
ski mRNA in the uterus of OVX+E2-treated rats. A: 0 h (OVX but
no E2 injected). B, C, D, E and F: 1, 3, 6, 12 and 24 h after E2
treatment, respectively. Magni¢cation, U140.
Fig. 4. Immunohistochemical analysis on the expression of PCNA
in the uterus of OVX+E2-treated rats. A: 0 h (OVX but no E2 in-
jected). B and C: 6 and 24 h after E2 treatment, respectively. D:
The same staining procedure was applied to the section from rat
small intestine. Magni¢cation, U300.
Table 1
Changes in the distribution of c-ski positive cells in the uterus of
ovariectomized rat after a single injection of estradiol-17L (E2)
Time after E2 injection (h) Epithelium Stroma
Glandular Luminal
0 + 3 +
1 + 3 +
3 ++ + +
6 ++ ++ +
12 ++ ++ +
24 ++ ++ +
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(P6 0.05) increased 3^6 h after the treatment. Therefore the
increased expression of c-ski message observed in RT-PCR
analysis may be concluded to represent its epithelial expres-
sion induced by E2 treatment. Since uterine stromal cells lose
their ability to proliferate in response to E2 during the ma-
turational process [15], this is in good agreement with our
result that the relatively low expression in the subepithelial
stromal cells was unchanged regardless of E2 treatment.
The uterine epithelial cells are known to respond to in vivo
E2 treatment and proliferate as shown by several studies
[7,16]. In the mature, ovariectomized rat model, estradiol
treatment induces DNA synthesis 12^16 h after treatment,
and mitosis follows at 18^24 h [17]. This was also con¢rmed
in our study in which the expression of PCNA was evident in
uterine epithelial cells of OVX rats 24 h after E2 treatment.
Although the precise function of c-ski expressed in the uterus
is unknown at present, we would present one possibility that
this gene is involved in mediating the proliferative e¡ect of E2
on uterine epithelial cells. The animal model used in the
present experiment was according to the previous reports by
several groups [6,7] so that we could directly compare the
results obtained with theirs, i.e. they used ovariectomized
adult female rats and treated them with a single injection
(s.c., 1 Wg in sesame oil) of E2. Among these reports, the
temporal and cellular expression patterns of c-fos mRNA [7]
as well as its translated product Fos [6] were investigated and
its role in the proliferation of uterine epithelial cells was sug-
gested [5^7,18]. In these studies, the expression of c-fos mes-
sage (and protein) was transient, and peaked earlier than that
of c-ski. Comparing their results with ours, there was a 5 h
interval in the period of its peak/maximum expression
achieved between c-fos (1 h, by Papa et al. [6]) and c-ski (6
h, the present study). The regulatory mechanism of c-ski gene
expression is currently unknown, however, it should be noted
that the DNA sequencing analysis on the homologue of c-ski
gene, snoN, revealed that this gene has an AP-1 binding site
[19], a well known regulatory region to which Fos binds to-
gether with Jun [20], in its 5P promoter region. This led us to
the hypothesis that Fos, induced rapidly and transiently by
E2, sequentially acts on the regulatory region of the c-ski gene
and promotes its transcription, although the possibility that
E2 directly induces c-ski gene expression cannot be excluded.
To clarify this issue, more detailed study on the regulatory
mechanism of c-ski/sno gene expression will be required in the
near future.
In conclusion, our study clearly indicates that the expres-
sion of c-ski gene is speci¢cally induced in the uterine epithe-
lial cells of OVX rats by E2 treatment, and suggests that c-ski
is involved in mediating proliferative e¡ect of E2 in these cells.
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